REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Couldn't agree more. Predicting revenue's itself can cause issues in terms of expectations so lets let the Company do the talking.
IMHO, a CEO should aim for conservative figures if put in the public domain (£4m FY 2020) because miss it by 20% it is essentially a profit warning - I doubt GB is so naive to be so clumsy. The flipside, PI can cause their own problem by getting giddy by predicting silly numbers. Let the company do the talking on this front.
The market is c6 month behind the company's development - Take advantage if you can, I have.
yep good post Sharebag, I can't think that GB has let us down thus far, he can't do much more to help the share price along than he is already doing.
I agree too regarding next years numbers, he will most certainly have played it cautiously, who wouldn't far better to under promise and over deliver which, failing any catastrophe, will surely happen here, I believe the numbers were mostly based on current understanding of potential clients and not necessarily assuming new ones who will undoubtedly come as the year unfolds. I have not quite reached my target share number yet, keep looking to bag a few more at some point when funds allow and only at under 1.8p so in some ways happy for it to be drifting here but if I miss the boat then so be it I have enough.
We have been at 2p previously and that was prior to much of the latest news so see no reason whatsoever that we will not return there this year. Absolutely a LT hold for me, have not even really thought about an exit at this stage because I remain unclear where this could go given time.
Yes this share always seems to end up down after each positive RNS. Completely bonkers. Such huge potential if this management can keep making deals. SKIN deserves higher valuation surely?
Good post sharebag, had a wee top up earlier
Here we are. GB has stated 1 million rev will be reached for 2019 and it has - what more can one do? We are getting more tangible value day by day, week on week and month on month. 4 mill predicted for 2020 - who would hedge a bet that wont happen? If anything that figure may be blasted out of the park imo, I think GB used a 'safe' figure, to avoid of the risk of falling short.
Traders have traded this stock very nicely as it has hovered within a range but the big money is made in waiting. Blue sky stock imo given the fundamentals we have now and the service/products we are able to provide. I am sticking here at-least a couple years and will play it as-long as I think more value will be bought into Integumen.
Look back last year and tell me we have not made massive gains in what GB has so far done? The sales team came in only back in approx June 2019, so had a proper 4 months (couple month to bed-in). We have been 2/3 conferences and we will see in due course what we have gained from them. My guess is we will have acquired a good few big contracts! Then there is news on grant funding to come at some point which can be worth approx. $7.7 million.
Conviction in the fundamentals is needed and avoid some accounts who are persistent in telling you to avoid this stock. By all means listen but go with your own research. That way there is no one to blame.